Cargando…

Mantle Cell Lymphoma Relapsing at the Lymphedematous Arm

Lymphedema (LE) is a chronic medical condition characterized by lymphatic fluid retention, resulting in tissue swelling. Cancer treatments involving lymph nodes can damage lymph drainage routes, causing accumulation of lymph fluid in the interstitial tissue of related limbs and body areas and second...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massini, Giuseppina, Hohaus, Stefan, D’Alò, Francesco, Bozzoli, Valentina, Vannata, Barbara, Larocca, Luigi Maria, Teofili, Luciana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591278/ https://www.ncbi.nlm.nih.gov/pubmed/23505604 http://dx.doi.org/10.4084/MJHID.2013.016

Ejemplares similares

Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young Type 3
por: Bozzoli, Valentina, et al.
Publicado: (2012)

Combined Modality Treatment Including Methotrexate-Based Chemotherapy For Primary CENTRAL Nervous System Lymphoma: A Single Institution Experience
por: Hohaus, Stefan, et al.
Publicado: (2009)

Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021)

Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Burkitt Lymphoma as Fourth Neoplasia in a Patient Affected by Cowden Syndrome with a Novel PTEN Germline Pathogenic Variant
por: Galli, Eugenio, et al.
Publicado: (2020)

Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy
por: Hohaus, Stefan, et al.
Publicado: (2017)

Neutrophilic Dermatosis Confined to the Lymphedematous Area
por: Park, Ji-Youn, et al.
Publicado: (2014)

Erratum: Neutrophilic Dermatosis Confined to the Lymphedematous Area
por: Park, Ji-Youn, et al.
Publicado: (2017)

Comparison of Various Kinds of Probes for Lymphedematous Limbs
por: Hara, Hisako, et al.
Publicado: (2021)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden
por: Leccisotti, Lucia, et al.
Publicado: (2022)

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2016)

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
por: Hohaus, Stefan, et al.
Publicado: (2018)

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
por: Broccoli, Alessandro, et al.
Publicado: (2018)

Challenges of cellulitis in a lymphedematous extremity: a case report
por: Connor, Matthew Pierce, et al.
Publicado: (2009)

Extraosseous Ewing sarcoma arising in a chronically lymphedematous limb
por: McArdle, David John Tobias, et al.
Publicado: (2018)

PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2022)

Obesity-Associated Lymphedematous Mucinosis: Two Further Cases and Review of the Literature
por: Ferreli, Caterina, et al.
Publicado: (2018)

The feasibility of a fiber optic laser approach to relieving lymphedematous syndrome: a case report
por: Palmieri, Beniamino, et al.
Publicado: (2013)

Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
por: Samad, Nousheen, et al.
Publicado: (2010)

Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma
por: Galimberti, S, et al.
Publicado: (2010)

Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience
por: Bellisario, Flaminia, et al.
Publicado: (2023)

Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?
por: Kirschey, Sebastian, et al.
Publicado: (2012)

Relapsed/Refractory Mantle Cell Lymphoma: Beyond BTK Inhibitors
por: Burkart, Madelyn, et al.
Publicado: (2022)

Enhancement of Lymphatic Vessels in the Superficial Layer in a Rat Model of a Lymphedematous Response
por: Matsumoto, Kumiko, et al.
Publicado: (2018)

Relapsed Mantle Cell Lymphoma Presenting as “Sister Mary Joseph Nodule”
por: Vaughn, Jennifer E., et al.
Publicado: (2010)

Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
por: Peterson, Derek, et al.
Publicado: (2014)

Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
por: Aydilek, Enver, et al.
Publicado: (2023)

Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population
por: Cingolani, Antonella, et al.
Publicado: (2017)

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
por: Iacoboni, Gloria, et al.
Publicado: (2022)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma
por: Borgerding, Andrea, et al.
Publicado: (2009)

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2016)

Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions
por: Bond, David A, et al.
Publicado: (2021)

Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma
por: Portell, Craig A., et al.
Publicado: (2022)

P1096: TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
por: Bock, A., et al.
Publicado: (2022)

CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
por: Vu, Khoan, et al.
Publicado: (2022)

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
por: Sawalha, Yazeed, et al.
Publicado: (2023)

A very unusual cause of dysphagia: mantle cell lymphoma
por: Zullo, Angelo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6o9ma79pmvnught20ccmu04rk3